These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 25444797

  • 1. Febrile seizures following measles and varicella vaccines in young children in Australia.
    Macartney KK, Gidding HF, Trinh L, Wang H, McRae J, Crawford N, Gold M, Kynaston A, Blyth C, Yvonne Z, Elliott E, Booy R, Buttery J, Marshall H, Nissen M, Richmond P, McInytre PB, Wood N, PAEDS (Paediatric Active Enhanced Disease Surveillance) Network.
    Vaccine; 2015 Mar 10; 33(11):1412-7. PubMed ID: 25444797
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Combination Measles-Mumps-Rubella-Varicella Vaccine Introduction in Australia.
    Macartney K, Gidding HF, Trinh L, Wang H, Dey A, Hull B, Orr K, McRae J, Richmond P, Gold M, Crawford N, Kynaston JA, McIntyre P, Wood N, Paediatric Active Enhanced Disease Surveillance Network.
    JAMA Pediatr; 2017 Oct 01; 171(10):992-998. PubMed ID: 28806450
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Policy statement—Prevention of varicella: update of recommendations for use of quadrivalent and monovalent varicella vaccines in children.
    Committee on Infectious Diseases.
    Pediatrics; 2011 Sep 01; 128(3):630-2. PubMed ID: 21873692
    [Abstract] [Full Text] [Related]

  • 6. Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children.
    Rowhani-Rahbar A, Fireman B, Lewis E, Nordin J, Naleway A, Jacobsen SJ, Jackson LA, Tse A, Belongia EA, Hambidge SJ, Weintraub E, Baxter R, Klein NP.
    JAMA Pediatr; 2013 Dec 01; 167(12):1111-7. PubMed ID: 24126936
    [Abstract] [Full Text] [Related]

  • 7. Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context.
    Casabona G, Berton O, Singh T, Knuf M, Bonanni P.
    Expert Rev Vaccines; 2023 Dec 01; 22(1):764-776. PubMed ID: 37642012
    [Abstract] [Full Text] [Related]

  • 8. Measles-containing vaccines and febrile seizures in children age 4 to 6 years.
    Klein NP, Lewis E, Baxter R, Weintraub E, Glanz J, Naleway A, Jackson LA, Nordin J, Lieu T, Belongia EA, Fireman B.
    Pediatrics; 2012 May 01; 129(5):809-14. PubMed ID: 22473362
    [Abstract] [Full Text] [Related]

  • 9. Safety of measles-containing vaccines in 1-year-old children.
    Klein NP, Lewis E, Fireman B, Hambidge SJ, Naleway A, Nelson JC, Belongia EA, Yih WK, Nordin JD, Hechter RC, Weintraub E, Baxter R.
    Pediatrics; 2015 Feb 01; 135(2):e321-9. PubMed ID: 25560438
    [Abstract] [Full Text] [Related]

  • 10. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V.
    Cochrane Database Syst Rev; 2021 Nov 22; 11(11):CD004407. PubMed ID: 34806766
    [Abstract] [Full Text] [Related]

  • 11. Modelling Hospitalisation Ratios for Febrile Convulsions and Severe Varicella Under Combined Measles, Mumps, Rubella, and Varicella (MMRV-Priorix-Tetra™) Compared to Separate MMR + V Vaccination.
    Bauchau V, Van Holle L, Cohen C.
    Drug Saf; 2015 Nov 22; 38(11):1095-102. PubMed ID: 26251259
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y, Steri GC, Behre U, Arsène JP, Lanse X, Helm K, Esposito S, Meister N, Desole MG, Douha M, Willems P.
    Vaccine; 2009 Jan 14; 27(3):446-53. PubMed ID: 19007835
    [Abstract] [Full Text] [Related]

  • 13. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
    Halperin SA, Ferrera G, Scheifele D, Predy G, Stella G, Cuccia M, Douha M, Willems P.
    Vaccine; 2009 May 05; 27(20):2701-6. PubMed ID: 19428882
    [Abstract] [Full Text] [Related]

  • 14. Impact of history of febrile convulsions on the risk difference of febrile convulsions with the tetravalent measles-mumps-rubella-varicella vaccine: Post-hoc exploratory analysis of results from a matched-cohort study.
    Gvozdenovic E, Vetter V, Willame C, Rosillon D.
    Vaccine; 2018 Sep 18; 36(39):5803-5806. PubMed ID: 30131195
    [Abstract] [Full Text] [Related]

  • 15. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures.
    Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, Baxter R, Hambidge S, Nordin J, Naleway A, Belongia EA, Lieu T, Baggs J, Weintraub E, Vaccine Safety Datalink.
    Pediatrics; 2010 Jul 18; 126(1):e1-8. PubMed ID: 20587679
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T, Baer M, Willems P.
    Pediatr Infect Dis J; 2007 Feb 18; 26(2):153-8. PubMed ID: 17259879
    [Abstract] [Full Text] [Related]

  • 17. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
    Goh P, Lim FS, Han HH, Willems P.
    Infection; 2007 Oct 18; 35(5):326-33. PubMed ID: 17710370
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
    Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P.
    Pediatr Infect Dis J; 2008 Aug 18; 27(8):724-30. PubMed ID: 18600190
    [Abstract] [Full Text] [Related]

  • 19. Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination.
    Schink T, Holstiege J, Kowalzik F, Zepp F, Garbe E.
    Vaccine; 2014 Feb 03; 32(6):645-50. PubMed ID: 24374498
    [Abstract] [Full Text] [Related]

  • 20. Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study.
    MacDonald SE, Dover DC, Simmonds KA, Svenson LW.
    CMAJ; 2014 Aug 05; 186(11):824-9. PubMed ID: 24914115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.